- Changes to medications that affect edema within the last 30 days prior to enrollment (e.g. diuretics, calcium channel blockers of the dihyropyridine class, pioglitazone, cox-1 inhibitors, pregabalin, and gabapentin, diltiazem or fluctuating doses of systemic steroids).